Lipid profile regulation via phytosterol intake

"Lipid profile regulation via phytosterol intake" does not refer to a specific molecular target such as an enzyme, receptor, transporter, or gene product; instead it describes the physiological effect achieved through dietary consumption of plant-derived sterols ("phytosterols"). Phytosterols structurally resemble cholesterol and compete with it for intestinal absorption by being incorporated into mixed micelles during digestion. This competition reduces overall uptake and increases fecal excretion of both dietary and biliary cholesterol. The net result is reduced serum total and especially low-density lipoprotein (LDL) cholesterol concentrations—an established risk factor modification for cardiovascular disease prevention. The primary molecular mediators involved are ATP-binding cassette transporters ABCG5/ABCG8 that actively efflux absorbed phytosterols back into the gut lumen or bile, limiting their systemic bioavailability compared to endogenous or dietary animal-derived cholesterols. Phytosterol-enriched foods have been shown to lower LDL-cholesterol by 8–10% at daily intakes around 2 grams per day; they can be used alongside statins or ezetimibe but should not replace prescription medications without medical supervision[1][2][3][4]. Because this entry describes an effect rather than an individual molecule/protein/receptor/gene product typically considered as "therapeutic targets," it is not itself considered a canonical drug target but rather represents an important nutritional intervention point within lipid metabolism pathways. If you require information about specific molecular targets involved in this process—such as "ATP-binding cassette sub-family G member 5" (ABCG5), "ATP-binding cassette sub-family G member 8" (ABCG8), "Low-density lipoprotein receptor" (LDLR), or enzymes like "HMG-CoA reductase"—please specify so structured data can be provided accordingly.

Other names

Phytosterol-mediated cholesterol loweringPlant sterol-induced lipid modulationDietary phytosterols and cholesterol metabolism

Phytosterols lower serum LDL-cholesterol by competing with dietary and biliary cholesterol for incorporation into mixed micelles in the intestine, thereby reducing intestinal absorption of cholesterol. This leads to increased excretion of unabsorbed cholesterol in feces. The resulting decrease in circulating LDL triggers upregulation of hepatic LDL receptors, enhancing clearance of LDL from the blood. Phytosterols do not inhibit HMG-CoA reductase directly but complement statin therapy by acting at the level of intestinal absorption rather than synthesis[1][4].